Mirae Asset Global Investments Co., Ltd. Travere Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,767 shares of TVTX stock, worth $48,865. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,767
Previous 2,273
21.73%
Holding current value
$48,865
Previous $18,000
111.11%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TVTX
# of Institutions
186Shares Held
89.5MCall Options Held
137KPut Options Held
184K-
Black Rock Inc. New York, NY7.64MShares$135 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$132 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$130 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$117 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$79.2 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.13B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...